The Pathobiology of Endothelin-1 in Vein Graft Disease: Are ETA Receptor Antagonists the Solution to Prevent Vein Graft Failure?

Publisher： Bentham Science Publishers

E-ISSN： 1875-6212|3|4|315-323

ISSN： 1570-1611

Source： Current Vascular Pharmacology, Vol.3, Iss.4, 2005-10, pp. : 315-323

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Saphenous Vein Graft Disease and Serum Erythropoietin Level

By  

Medical Principles and Practice, Vol. 25, Iss. 5, 2016-03 ,pp. : 498-498

Karger

Access to resources Recommend Favorite

Platelets and saphenous vein graft failure following coronary artery bypass surgery

By Jeremy J.Y.   Mehta D.   Bryan A.J.   Lewis D.   Angelini G.D.  

Platelets, Vol. 8, Iss. 5, 1997-09 ,pp. : 295-310

Informa Healthcare

Access to resources Recommend Favorite

New therapeutic possibilities for vein graft disease in the post-edifoligide era

By Cai Xinjiang   Freedman Neil J  

Future Cardiology, Vol. 2, Iss. 4, 2006-07 ,pp. : 493-501

Future Medicine

Access to resources Recommend Favorite

Plateletcrit: A platelet marker associated with saphenous vein graft disease

By Akpinar I.   Sayin M.R.   Gursoy Y.C.   Karabag T.   Kucuk E.   Buyukuysal M.C.   Aydin M.   Haznedaroglu I.C.  

Herz, Vol. 39, Iss. 1, 2014-02 ,pp. : 142-148

Springer Publishing Company

Access to resources Recommend Favorite

Saphenous Vein Graft Disease Is Associated with a Low Serum Erythropoietin Level

By  

Medical Principles and Practice, Vol. 24, Iss. 6, 2015-0 ,pp. : 544-547

Karger

Access to resources Recommend Favorite